BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1192 related articles for article (PubMed ID: 24410954)

  • 1. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study.
    Faxén-Irving G; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Hjorth E; Palmblad J; Vedin I; Cederholm T; Wahlund LO
    J Alzheimers Dis; 2013; 36(1):1-6. PubMed ID: 23563245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J
    J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Vedin I; Hjorth E; Basun H; Faxén Irving G; Schultzberg M; Eriksdotter M; Palmblad J; Vessby B; Wahlund LO; Cederholm T; Basu S
    J Alzheimers Dis; 2014; 42(3):823-31. PubMed ID: 24934544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
    Safarinejad MR
    Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
    Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
    Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex, Body Mass Index, and APOE4 Increase Plasma Phospholipid-Eicosapentaenoic Acid Response During an ω-3 Fatty Acid Supplementation: A Secondary Analysis.
    Loukil I; Aguilera EC; Vachon A; Léveillé P; Plourde M
    J Nutr; 2024 May; 154(5):1561-1570. PubMed ID: 38513888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study.
    Vedin I; Cederholm T; Freund-Levi Y; Basun H; Garlind A; Irving GF; Eriksdotter-Jönhagen M; Wahlund LO; Dahlman I; Palmblad J
    PLoS One; 2012; 7(4):e35425. PubMed ID: 22545106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study.
    Karimi M; Vedin I; Freund Levi Y; Basun H; Faxén Irving G; Eriksdotter M; Wahlund LO; Schultzberg M; Hjorth E; Cederholm T; Palmblad J
    Am J Clin Nutr; 2017 Oct; 106(4):1157-1165. PubMed ID: 28855224
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
    Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
    Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid incorporation of ω-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.
    Sorensen LS; Rasmussen HH; Aardestrup IV; Thorlacius-Ussing O; Lindorff-Larsen K; Schmidt EB; Calder PC
    JPEN J Parenter Enteral Nutr; 2014 Jul; 38(5):617-24. PubMed ID: 23788002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation of docosahexaenoic acid (DHA) / Eicosapentaenoic acid (EPA) in a ratio of 1/1.3 during the last trimester of pregnancy results in EPA accumulation in cord blood.
    Büyükuslu N; Ovalı S; Altuntaş ŞL; Batırel S; Yiğit P; Garipağaoğlu M
    Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():32-36. PubMed ID: 28987719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: effects of omega-3 polyunsaturated fatty acid supplementation.
    Signorini C; De Felice C; Leoncini S; Durand T; Galano JM; Cortelazzo A; Zollo G; Guerranti R; Gonnelli S; Caffarelli C; Rossi M; Pecorelli A; Valacchi G; Ciccoli L; Hayek J
    Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):183-93. PubMed ID: 25240461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.